InMed Pharmaceuticals Inc

NASDAQ:INM  
2.84
-0.09 (-3.07%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

InMed Pharmaceuticals Inc Stock, NASDAQ:INM

815 West Hastings Street, Suite 310, Vancouver, British Columbia V6C 1B4
Canada
Phone: +1.604.669.7207
Number of Employees:

Description

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.